Tradestie Institutional Equity Comparison Engine

ADMA vs ELVN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ADMA Overall Edge

ADMA Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to ADMA Biologics, Inc. (ADMA) driven by superior Valuation, Growth & Margin, Options & Structure while ELVN counters with relative strength in Momentum & Technical. Fundamentally, ADMA trades at 15.7x Forward P/E with 44.9% operating margin (+5.1% YoY revenue) versus ELVN at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, ADMA sits in SURGE (8th %ile IV; Dealer Gamma Walls on Pro) against ELVN sits in CONSOLIDATION (5th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ADMA
ADMA 15.7x vs ELVN N/M Fwd P/E
Growth & Margin Winner ADMA
Op Margin 44.9% vs 0.0% ยท YoY +5.1% vs +0.0%
Momentum & Technical Winner ELVN
1Y -12.8% vs +134.5% ยท 52W Pos 49% vs 69%
Options & Structure Winner ADMA
SURGE (8th %ile IV) vs CONSOLIDATION (5th %ile IV)
ADMA NASDAQ
ADMA Biologics, Inc.
Biological Products, (No Disgnostic Substances)
$13.70
+0.11% 1D
Market Cap $2.9B
1M Return +28.23%
1Y Return -12.77%
Forward P/E 15.7x
Unified AI Score
23.7 / 100 STRONG SELL
Tech 50.0 Fund 35.0 Flow 66.0 Mom 25.9
ELVN NASDAQ
Enliven Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$47.54
-2.58% 1D
Market Cap $3.6B
1M Return +27.38%
1Y Return +134.53%
Forward P/E N/M
Unified AI Score
36.2 / 100 SELL
Tech 15.0 Fund 44.0 Flow 68.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ADMA -12.77% ELVN +134.53% Spread: +147.3 pp (ELVN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ADMA TTM Op. Margin: 44.9% ELVN TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ADMA vs ELVN. Trailing 12-month operating profitability (ADMA 44.9% vs ELVN 0.0%) and valuation multiples (ADMA 15.7x vs ELVN N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ADMA (6) vs ELVN (4)
Institutional Metric ADMA ELVN Criterion Row Winner
Market Capitalization Scale $2.9B $3.6B Larger Scale ELVN
Trailing P/E Ratio Valuation 17.2x N/M Lower Multiple ADMA
Forward P/E Ratio Valuation 15.7x N/M Lower Multiple ADMA
Revenue Growth (YoY) Growth +5.1% +0.0% Higher Growth ADMA
Operating Margin (TTM) Profitability 44.9% 0.0% Higher Margin ADMA
Net Profit Margin Profitability 35.1% 0.0% Higher Margin ADMA
Return on Equity (ROE) Capital Efficiency 41.9% -16.8% Higher ROE ADMA
52-Week Range Position Momentum 49% ($7โ€“$20) 69% ($15โ€“$62) Stronger Trend ELVN
Beta / 30D Volatility Risk Regime -0.42ฮฒ ยท 99% Vol 0.96ฮฒ ยท 60% Vol Lower Realized Risk ELVN
Unified Institutional Score Composite Signal 23.7 / 100 (STRONG SELL) 36.2 / 100 (SELL) Higher Composite ELVN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ADMA vs ELVN Buy Guide
ADMA SURGE
7d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 8th %ile
IV Regime Compressed (<25th %ile)
Live ADMA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ELVN CONSOLIDATION
59d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 5th %ile
IV Regime Compressed (<25th %ile)
Live ELVN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ADMA nor ELVN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.